Revenue: The sum of all revenue fields included for a company's operating activities.
Salarius Pharmaceuticals, Inc. (SLRX) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-5.58M |
|
-- |
|
-- |
|
$5.73M |
|
$-5.73M |
|
$0.16M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.73M |
|
$-5.73M |
|
0.96M |
|
0.96M |
|
$-5.79 |
|
$-5.79 |
|
| Balance Sheet Financials | |
$2.99M |
|
-- |
|
$0.04M |
|
$3.02M |
|
$1.51M |
|
-- |
|
-- |
|
$1.51M |
|
$1.51M |
|
$1.51M |
|
$1.51M |
|
1.44M |
|
| Cash Flow Statement Financials | |
$-4.53M |
|
-- |
|
$1.06M |
|
$5.90M |
|
$2.43M |
|
$-3.47M |
|
$0.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-368.84% |
|
-368.84% |
|
-184.45% |
|
-368.84% |
|
$1.05 |
|
$-4.70 |
|
$-4.70 |
|